Provided by Tiger Trade Technology Pte. Ltd.

CANSINOBIO

29.500
-2.260-7.12%
Volume:7.92M
Turnover:234.37M
Market Cap:7.29B
PE:268.18
High:30.840
Open:30.620
Low:28.820
Close:31.760
52wk High:56.550
52wk Low:19.220
Shares:247.04M
HK Float Shares:132.67M
Volume Ratio:0.46
T/O Rate:5.97%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.110
ROE:-0.02%
ROA:-0.83%
PB:1.27
PE(LYR):268.18
PS:5.57

Loading ...

CanSino Biologics Surges Over 35% as Analysts See Parallels with Moderna's Vaccine Platform

Stock News
·
Aug 20

CLSA Says CansinoBio Shares Surge as Moderna's mRNA Cancer Vaccine Succeeds in Late-Stage Trial

Stock News
·
Aug 20

HK Movers | Pharma Stocks Surge With 3D Medicines up 68%, CanSino Biologics up 52%

Tiger Newspress
·
Aug 20

Hong Kong Stock Alert: CansinoBio Jumps 15% as mRNA Cancer Vaccine Sector Gets Major Boost

Stock News
·
Aug 20

AH Premium Rankings Unveiled: August 18 Market Close Data

Stock News
·
Aug 18

Dual-Listed Stock Premium Rankings: August 17 Closing Data

Stock News
·
Aug 17

CanSino Biologics Says China's Nmpa Accepts New Drug Application for TD5cp Adolescent and Adult

THOMSON REUTERS
·
Aug 16

CanSino Biologics: Td5cp Vaccine for Adolescents and Adults Accepted for New Drug Review

Stock News
·
Aug 16

CANSINOBIO Receives NMPA Acceptance and Priority Review for Five-Component DTaP Booster Vaccine

Bulletin Express
·
Aug 16

Dual-Listed Stock Premium Ranking: August 14 Market Close

Stock News
·
Aug 14

CANSINOBIO Reports Zero Share Capital Changes for July 2026; 860,000 H-Share Options Remain Outstanding

Bulletin Express
·
Aug 04

AH Share Premium and Deviation Data for July 20th

Stock News
·
Jul 20

CANSINOBIO Shares Surge on Regulatory Progress for Meningitis Vaccine

Stock News
·
Jul 20

CanSino Biologics Gets NMPA Nod to Review Supplemental Application Expanding Menhycia® Age Range

Bulletin Express
·
Jul 19

CansinoBIO Receives NMPA Acceptance for Age Extension of MenQuad Vaccine

Stock News
·
Jul 19

AH Share Premium and Deviation Rankings as of July 13th Close

Stock News
·
Jul 13

CANSINOBIO Sees Stable Share Capital in June 2026; Public Float Meets HKEX Requirement

Bulletin Express
·
Jul 03

AH Share Premium and Deviation Rankings for July 3rd

Stock News
·
Jul 03

CanSino Biologics Gets Registration Certificate for Meningitis Vaccine in Argentina

MT Newswires Live
·
Jun 25

CanSino Biologics: MCV4 Vaccine Gains Argentine Registration, Advancing Global Strategy

Bulletin Express
·
Jun 25